Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-Regional, Open-label, Three-Part Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Aom0304 in Adult Patients With Symptomatic Hypertrophic Cardiomyopathy

NCT07675668 is registered in ClinicalTrials.gov with Amckaus PTY LTD. as lead sponsor.

NCT NCT07675668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07675668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-Regional, Open-label, Three-Part Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Aom0304 in Adult Patients With Symptomatic Hypertrophic Cardiomyopathy
Lead sponsor
Amckaus PTY LTD.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 30, 2028
Enrollment
56 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy (hcm), non-obstructive hcm (nhcm), obstructive hcm (ohcm)